|HEITT, KELLI - US Department Of Agriculture (USDA)|
|WOOLSEY, REBEKAH - University Of Nevada|
|SCHEGG, KATHLEEN - University Of Nevada|
|Line, John - Eric|
Submitted to: Meeting Abstract
Publication Type: Abstract Only
Publication Acceptance Date: 6/9/2015
Publication Date: 6/12/2015
Citation: Swift, S., Seal, B.S., Garrish, J.K., Oakley, B., Yeh, H., Heitt, K., Woolsey, R., Schegg, K.M., Line, J.E., Donovan, D.M. 2015. A thermophilic phage endolysin fusion to a Clostridium perfringens-specific cell wall binding domain creates an anti-clostridium antimicrobial with improved thermostability. Meeting Abstract. 12;7(6):3019-34. doi: 10.3390/v7062758.
Technical Abstract: Clostridium perfringens is the third leading cause of human foodborne bacterial disease and is the presumptive etiologic agent of Necrotic enteritis among chickens. Treatment of poultry with antibiotics is becoming less acceptable. Endolysin enzymes are potential replacements for antibiotics. Many enzymes are added to animal feed during production and are subjected to high-heat stress during feed processing. To produce a thermostabile endolysin for treating poultry, an E. coli codon-optimized gene was synthesized that fused the N-acetylmuramoyl-L-alanine amidase domain from the endolysin of the thermophilic bacteriophage to the cell wall binding domain from the endolysin of a C. perfringens-specific bacteriophage. The resulting protein lysed C. perfringens in liquid and solid cultures, was most active at pH8, had peak activity at 10 mM NaCl, 40% activity at 150 mM NaCl and was still 16% active at 600 mM NaCl. The protein was able to withstand temperatures up to 50°C and still lyse C. perfringens. Herein we report the construction and characterization of a thermostabile chimeric endolysin that could potentially be utilized as a feed additive to control the bacterium during poultry production.